Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
A first-in-human, open-label, dose escalation and expansion study of orally administered NX-019 in patients with advanced EGFR mutant cancer.
- Authors
- Spira, AI[Spira, Alexander I.]; Kim, DW[Kim, Dong-Wan]; Ahn, MJ[Ahn, Myung-Ju]; Kim, SW[Kim, Sang-We]; Hong, MH[Hong, Min Hee]; Dusek, R[Dusek, Rachel]; Gammon, GM[Gammon, Guy M.]; Wilson, K[Wilson, Keith]; Yang, JCH[Yang, James Chih-Hsin]; Massarelli, E[Massarelli, Erminia]
- Issue Date
- 1-Jun-2023
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.41, no.16
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 41
- Number
- 16
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.